Long-Term Extension Study of Miravirsen Among Participants With Genotype 1 Chronic Hepatitis C (CHC) Who Have Not Responded to Pegylated-Interferon Alpha Plus Ribavirin
Clinical trial NCT02508090 · COMPLETED
Trial details
- NCT number
- NCT02508090
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-08-02
- Primary completion
- 2017-01-13
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.